These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

343 related articles for article (PubMed ID: 8821595)

  • 1. Interactions of liposomal amphotericin B with extracellular and intracellular Candida albicans.
    van Etten EW; Chander HR; Snijders SV; Bakker-Woudenberg IA
    J Antimicrob Chemother; 1995 Dec; 36(6):961-74. PubMed ID: 8821595
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Activity of liposomal amphotericin B with prolonged circulation in blood versus those of AmBisome and fungizone against intracellular Candida albicans in murine peritoneal macrophages.
    van Etten EW; van Vianen W; Hak J; Bakker-Woudenberg IA
    Antimicrob Agents Chemother; 1998 Sep; 42(9):2437-9. PubMed ID: 9736579
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Efficacies of amphotericin B-desoxycholate (Fungizone), liposomal amphotericin B (AmBisome) and fluconazole in the treatment of systemic candidosis in immunocompetent and leucopenic mice.
    van Etten EW; van den Heuvel-de Groot C; Bakker-Woudenberg IA
    J Antimicrob Chemother; 1993 Nov; 32(5):723-39. PubMed ID: 8125837
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmacokinetics, excretion, and mass balance of liposomal amphotericin B (AmBisome) and amphotericin B deoxycholate in humans.
    Bekersky I; Fielding RM; Dressler DE; Lee JW; Buell DN; Walsh TJ
    Antimicrob Agents Chemother; 2002 Mar; 46(3):828-33. PubMed ID: 11850268
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Amphotericin B liposomes with prolonged circulation in blood: in vitro antifungal activity, toxicity, and efficacy in systemic candidiasis in leukopenic mice.
    van Etten EW; ten Kate MT; Stearne LE; Bakker-Woudenberg IA
    Antimicrob Agents Chemother; 1995 Sep; 39(9):1954-8. PubMed ID: 8540697
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Topical amphotericin B in ultradeformable liposomes: Formulation, skin penetration study, antifungal and antileishmanial activity in vitro.
    Perez AP; Altube MJ; Schilrreff P; Apezteguia G; Celes FS; Zacchino S; de Oliveira CI; Romero EL; Morilla MJ
    Colloids Surf B Biointerfaces; 2016 Mar; 139():190-8. PubMed ID: 26709977
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evaluation of antifungal pharmacodynamic characteristics of AmBisome against Candida albicans.
    Takemoto K; Yamamoto Y; Ueda Y
    Microbiol Immunol; 2006; 50(8):579-86. PubMed ID: 16924142
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Plasma protein binding of amphotericin B and pharmacokinetics of bound versus unbound amphotericin B after administration of intravenous liposomal amphotericin B (AmBisome) and amphotericin B deoxycholate.
    Bekersky I; Fielding RM; Dressler DE; Lee JW; Buell DN; Walsh TJ
    Antimicrob Agents Chemother; 2002 Mar; 46(3):834-40. PubMed ID: 11850269
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Biodistribution of liposomal amphotericin B (AmBisome) and amphotericin B-desoxycholate (Fungizone) in uninfected immunocompetent mice and leucopenic mice infected with Candida albicans.
    van Etten EW; Otte-Lambillion M; van Vianen W; ten Kate MT; Bakker-Woudenberg AJ
    J Antimicrob Chemother; 1995 Apr; 35(4):509-19. PubMed ID: 7628985
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Heat-induced reformulation of amphotericin B-deoxycholate favours drug uptake by the macrophage-like cell line J774.
    Chéron M; Petit C; Bolard J; Gaboriau F
    J Antimicrob Chemother; 2003 Dec; 52(6):904-10. PubMed ID: 14613963
    [TBL] [Abstract][Full Text] [Related]  

  • 11. In vitro pharmacodynamics of rapid versus continuous infusion of amphotericin B deoxycholate against Candida species in the presence of human serum albumin.
    Lewis RE; Wiederhold NP; Prince RA; Kontoyiannis DP
    J Antimicrob Chemother; 2006 Feb; 57(2):288-93. PubMed ID: 16387749
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of amphotericin B and fluconazole on the extracellular and intracellular growth of Candida albicans.
    van Etten EW; van de Rhee NE; van Kampen KM; Bakker-Woudenberg IA
    Antimicrob Agents Chemother; 1991 Nov; 35(11):2275-81. PubMed ID: 1804000
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Supramolecular Chitosan Micro-Platelets Synergistically Enhance Anti-Candida albicans Activity of Amphotericin B Using an Immunocompetent Murine Model.
    Grisin T; Bories C; Bombardi M; Loiseau PM; Rouffiac V; Solgadi A; Mallet JM; Ponchel G; Bouchemal K
    Pharm Res; 2017 May; 34(5):1067-1082. PubMed ID: 28168390
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Role of macrophages in the candidacidal activity of liposomal amphotericin B.
    Mehta RT; Poddar S; Kalidas M; Gomez-Flores R; Dulski K
    J Infect Dis; 1997 Jan; 175(1):214-7. PubMed ID: 8985224
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antifungal activity of amphotericin B cochleates against Candida albicans infection in a mouse model.
    Zarif L; Graybill JR; Perlin D; Najvar L; Bocanegra R; Mannino RJ
    Antimicrob Agents Chemother; 2000 Jun; 44(6):1463-9. PubMed ID: 10817694
    [TBL] [Abstract][Full Text] [Related]  

  • 16. AmBisome and Amphotericin B inhibit the initial adherence of Candida albicans to human epithelial cell lines, but do not cause yeast detachment.
    Dorocka-Bobkowska B; Düzgüneş N; Konopka K
    Med Sci Monit; 2009 Sep; 15(9):BR262-9. PubMed ID: 19721394
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Water-soluble amphotericin B-polyvinylpyrrolidone complexes with maintained antifungal activity against Candida spp. and Aspergillus spp. and reduced haemolytic and cytotoxic effects.
    Charvalos E; Tzatzarakis MN; Van Bambeke F; Tulkens PM; Tsatsakis AM; Tzanakakis GN; Mingeot-Leclercq MP
    J Antimicrob Chemother; 2006 Feb; 57(2):236-44. PubMed ID: 16361329
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of LNS-AmB, a novel low-dose formulation of amphotericin B with lipid nano-sphere (LNS), with commercial lipid-based formulations.
    Fukui H; Koike T; Nakagawa T; Saheki A; Sonoke S; Tomii Y; Seki J
    Int J Pharm; 2003 Nov; 267(1-2):101-12. PubMed ID: 14602388
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparative capacity of four antifungal agents to stimulate murine macrophages to produce tumour necrosis factor alpha: an effect that is attenuated by pentoxifylline, liposomal vesicles, and dexamethasone.
    Louie A; Baltch AL; Franke MA; Smith RP; Gordon MA
    J Antimicrob Chemother; 1994 Dec; 34(6):975-87. PubMed ID: 7730240
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antimicrobial activity of AmBisome and non-liposomal amphotericin B following uptake of Candida glabrata by murine epidermal Langerhans cells.
    Sperry PJ; Cua DJ; Wetzel SA; Adler-Moore JP
    Med Mycol; 1998 Jun; 36(3):135-41. PubMed ID: 9776826
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.